East Rutherford, NJ - September 22, 2014 - Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Jonathan Knight, Vice President of New Product Development, Lars Eklund, Technical lead for Cambrex, and Margus Eek, Head of R&D for Cambrex Tallinn, will be presenting a webinar entitled Managing the API Life Cycle: Cambrex Innovation, Process and Cost Improvement on Thursday, October 16, 2014 at 11 AM EDT (16:00 UK BST/ GMT +1).

This informative webinar will use case studies to detail and describe how customers can benefit from Cambrex's innovative approach to managing the Active Pharmaceutical Ingredient (API) life cycle through the development of new sustainable routes or processes. Such improvements can lead to additional IP protection, the reduction of cost of goods and the lowering of environmental footprints.

Join us as we explore and showcase how Cambrex can manage your API life cycle through innovation, process and cost improvements. The live broadcast includes a slide presentation and a Q&A session.

For more information or to register for this webinar, visitManaging the API Life Cycle: Cambrex Innovation, Process and Cost Improvementhttp://xtalks.com/API-Process-and-cost-Improvement.ashx.

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include biocatalysis, high potency APIs, high energy chemical synthesis, controlled substances and drug product formulations.www.cambrex.comhttp://www.cambrex.com/.

Contact:  Stephanie Harrison
Marketing Manager
Phone: 201.804.3061
Email: stephanie.harrison @cambrex.commailto:stephanie.harrison@cambrex.com

distributed by